tazobactam has been researched along with tavaborole in 1 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (tavaborole) | Trials (tavaborole) | Recent Studies (post-2010) (tavaborole) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 75 | 9 | 63 |
| Protein | Taxonomy | tazobactam (IC50) | tavaborole (IC50) |
|---|---|---|---|
| Leucine--tRNA ligase, cytoplasmic | Saccharomyces cerevisiae S288C | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussar, DA | 1 |
1 review(s) available for tazobactam and tavaborole
| Article | Year |
|---|---|
New drugs 2015, part 3.
Topics: Acids, Carbocyclic; Benzoxazines; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cephalosporins; Cyclopentanes; Drug Approval; Drug Combinations; Drug Therapy; Glucagon-Like Peptides; Guanidines; Humans; Imidazoles; Immunoglobulin Fc Fragments; Interferon-beta; Isoquinolines; Penicillanic Acid; Polyethylene Glycols; Pyridines; Quinuclidines; Recombinant Fusion Proteins; Tazobactam; Triazoles; United States; United States Food and Drug Administration | 2015 |